logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Immunomic Discovery Of Adjuvants And Candidate Subunit Vaccines 1st Edition Darren R Flower

  • SKU: BELL-4290068
Immunomic Discovery Of Adjuvants And Candidate Subunit Vaccines 1st Edition Darren R Flower
$ 31.00 $ 45.00 (-31%)

4.1

40 reviews

Immunomic Discovery Of Adjuvants And Candidate Subunit Vaccines 1st Edition Darren R Flower instant download after payment.

Publisher: Springer-Verlag New York
File Extension: PDF
File size: 3.79 MB
Pages: 314
Author: Darren R. Flower, Yvonne Perrie (auth.), Darren R. Flower, Yvonne Perrie (eds.)
ISBN: 9781461450696, 9781461450702, 1461450691, 1461450705
Language: English
Year: 2013
Edition: 1

Product desciption

Immunomic Discovery Of Adjuvants And Candidate Subunit Vaccines 1st Edition Darren R Flower by Darren R. Flower, Yvonne Perrie (auth.), Darren R. Flower, Yvonne Perrie (eds.) 9781461450696, 9781461450702, 1461450691, 1461450705 instant download after payment.

This volume will address an important emergent area within the field of immunomics: the discovery of antigens and adjuvants within the context of reverse vaccinology. Conventional approaches to vaccine design and development requires pathogens to be cultivated in the laboratory and the immunogenic molecules within them to be identifiable. Conventional vaccinology is no longer universally successful, particularly for recalcitrant pathogens. By using genomic information we can study vaccine development in silico: 'reverse vaccinology', can identify candidate subunits vaccines by identifying antigenic proteins and by using equally rational approaches to identify novel immune response-enhancing adjuvants.

Related Products